Abstract
Introduction
Several lines of evidence indicate that strenuous exercise, such as rigorous eccentric muscle contraction, may result in severe muscle wasting and functional deterioration [1, 2] . However, skeletal muscle tissue can regenerate via the activation of satellite cells [3, 4] , a population of quiescent myogenic cells, localized between the basal lamina and plasma membrane of the muscle fibre, capable of proliferating and differentiating in response to muscle injury or disease [5] . These cells are characterized by the expression of the paired box transcription factor Pax7, which is required for their survival and functions upstream of the expression of the myogenic regulator factors (MRFs) Myf5, MyoD, Mrf4 and myogenin [6, 7] . During muscle repair/regeneration, a small subpopulation of satellite cells does not execute the myogenic program and reconstitute a compartment of quiescent 'stem cell' (self renew), able to respond to repeated muscle injury [8, 9] . It is generally assumed that the mere presence of satellite cells is not sufficient to ensure a rapid functional recovery of the injured muscle and that the release of appropriate factors and the establishment of suitable microenvironment are even more important in determining the effectiveness of the myogenic response [10] [11] [12] . However, in the case of extended damage, the propensity for an enhanced inflammatory response and the excessive fibroblast proliferation and connective tissue deposition may exceed the ability of stem cells to pursue the myogenic program and the muscle's regenerative potential [10, 12] . Hence, the identification of factors and therapeutic interventions aiming at enhancing muscle regeneration and attenuating or preventing muscle damage and fibrosis would be very useful in order to preserve muscle functionality. Along this line, sphingosine 1-phosphate (S1P), a bioactive lipid present in a physiologic concentration in the plasma, exerts multiple biological functions, including the maintenance of skeletal muscle homeostasis, acting through S1P receptors [13, 14] . The inhibition of sphingosine kinase (SphK), the enzyme responsible for S1P formation, significantly reduces the amount of regenerating centrally nucleated myofibres in cardiotoxin-damaged muscle [15, 16] . Moreover, the administration of exogenous S1P has been shown to cause a dramatic reduction of muscle tension decline during fatigue [17] and attenuate the progress of denervation-induced muscle atrophy [18] suggesting that this bioactive sphingolipid may act as a myogenic trophic factor. In this context, studies from our group have demonstrated that S1P is capable to stimulate C2C12 myoblast differentiation and have identified the underlying cellular and molecular mechanisms [19] [20] [21] [22] [23] [24] . Finally, there is evidence to support a role for the sphingolipid in the stimulation of extracellular matrix remodelling and in the regulation of matrix metalloproteinase 9 (MMP-9) expression in cardiomyocytes and skeletal myoblasts [25] [26] [27] [28] . Interestingly, changes in extracellular matrix composition are considered as crucial steps for the restoration of the tissue architecture during skeletal muscle regeneration [29] .
Based on these considerations, in the present study we further investigated the beneficial effects of S1P on skeletal muscle repair/regeneration, focusing our attention on the ability of this bioactive factor to protect the tissue against eccentric contraction (EC)-induced damage and exert its action on satellite cell function.
Materials and methods
The detailed version of materials and methods is reported in the supplemental file.
Animals and muscle injury model
Extensor digitorum longus (EDL) muscles were removed from anesthetized young adult Swiss mice (25-30 g ) and subjected to forced EC in isometric condition, in the absence or presence of 1 M S1P (ECϩ S1P) or of compound II, a SphK1 inhibitor (EC ϩ iSphK).
Morphological analysis of EDL skeletal muscle
Muscle tissue samples were fixed in buffered glutaraldehyde, post-fixed in phosphate-buffered OsO4 and routinely processed for light and transmission electron microscopy [30] . The severity of tissue damage was evaluated by counting the number of fibres showing key morphological signs of cell damage and evaluating the degree of injury in each fibre, using a semiquantitative histological score, as reported previously for similar purposes [31] . The criteria used are reported in Table 1 .
Lactate dehydrogenase (LDH) assay
LDH was assayed by oxidation of NADH with pyruvate [32] .
Western blotting
Protein aliquots (10-30 g ) from EDL muscle tissue and satellite cell-enriched fraction lysates were separated by a SDS-PAGE and immunoblotted as described previously [21] . Specific 
SphK activity
SphK activity was determined in control and EC-injured muscle by in vitro assay essentially as described previously [21] . Briefly, equal amounts of protein (20-60 g ) from muscle, were incubated in SphK1 and SphK2 specific assay buffer [35] 
S1P quantification in satellite cell-enriched fractions

Sphingolipids were quantified in satellite cell-enriched fractions from control and damaged muscles incubated with serum-free medium and 2 Ci of [ 3 H]sphingosine for 24 hrs at 37ЊC, essentially as reported
previously [21, 36] .
Confocal immunofluorescence
Cryostat [22] .
Culture of satellite cells isolated from single myofibres
Living single myofibres of EDL muscles were isolated and individually cultured as described previously [37] . After 
Determination of tissue fibrosis by Van Gieson staining
Cryostat EDL muscle sections (8 m) were fixed in paraformaldehyde vapours and stained with Van Gieson method for collagen [38] . (Fig. 1A and B) . By transmission electron microscopy (TEM) analyses, most of the muscle fibres exhibited moderate myofibrillar disarrangements and mitochondria alterations ( Fig. 1C and D) . Moreover, the treatment with S1P of EC muscle was capable of strongly attenuating the expression levels of the assayed apoptotic markers ( Fig. 2A) and caspase 3/7 activation (Fig. 2B) , reducing the percentage of apoptotic nuclei (approximately of 0.8.%; Fig. 2C ) and improving the examined electrophysiological parameters (Fig. 3, Table 2 ). The treatment with S1P of undamaged EDL muscle did not cause any morphological, biochemical and electrophysiological modifications (Figs 1-3 ).
Results
Exogenous S1P exerts protective effects during EC-induced muscle damage
Fig. 1 Protective effect of S1P against EC-induced structural and ultrastructural damage in EDL muscle fibre. (A) Light microscopy. Semi-thin sections from control, S1P-treated, EC-, EC ϩ S1P-and EC ϩ SphK1 inhibitor, compound II (iSphK)-injured skeletal muscles. EC-injured fibres showed substantial damage and some displayed signs of necrosis (inset). These structural abnormalities are attenuated in EC ϩ S1P muscle. Note that inhibition of the endogenous S1P production by iSphK does not confer much protection against EC damage. (B) Quantitative analysis of the number of damaged fibres expressed as percentage on the total fibre number (mean Ϯ S.E.M., One-way ANOVA *P Ͻ 0.05 versus specific control; ЊP Ͻ 0.05 versus EC; n ϭ 3). (C-D) Transmission electron microscopy. EC-damaged fibres display severe sarcomere disorganization and Z-disc disruption (arrows), together with swollen mitochondria with loss of organized cristae (asterisks) and dilated sarcoplasmic tubules (arrowheads).
In the presence of S1P, these ultrastructural alterations appear strongly attenuated.
EC also affected satellite cell functionality; in fact, cell viability, evaluated performing MTS assay in satellite cell-enriched fractions declined drastically in the injured muscle (Fig. 4) , suggesting that satellite cell metabolic activity could be impaired by muscle damage, as also previously reported [39] [40] [41] [42] . Interestingly, satellite cell viability resulted significantly higher in EC ϩ S1P muscle with respect to EC, thus extending the protective action of the sphingolipid in damaged skeletal muscle to the resident muscle stem cells (Fig. 4) .
All together, the above findings, indicated that EC caused muscle damage, consisting in a prevalence of necrotic over apoptotic cell death, and suggested that S1P exerted beneficial effects, protecting both the myofibres and adjacent satellite cells in these conditions.
EC induces endogenous SphK1 activation and S1P formation
We next searched whether EC caused the activation of the endogenous S1P synthesis in the injured muscle fibres, by evaluating the activity of two known SphK isoforms (SphK1 and SphK2), responsible for the production of the bioactive lipid in skeletal muscle [43] . As shown in Fig. 5A, (Fig. 6A) . Notably, in the presence of S1P, the pool of (Fig. 6B) . Satellite cell activation and viability was also investigated in the cells sprouting from cultured isolated myofibres (Fig. 7) . It was found that the number of viable muscle satellite cells derived from EC and EC ϩ S1P muscle fibres was significantly higher (approximately 1.5-and 2-fold, respectively) compared to control (Fig. 7A  and B) . In agreement, the sprouting myoblasts from EC and EC ϩ S1P-damaged fibres exhibited a higher tendency (approximately Table 2 . Fig. 7C-F) .
(C-D) Activation and inactivation Boltzmann curves for INa and ICa (Current to peak-V plots). RMP data and Boltzmann parameters are in
2-and 3-fold, respectively) to fuse into multinucleated myotubes than those from control (
In the absence of the muscle damage, the addition of S1P to the isolated EDL muscle did not affect the proliferating progeny nor modify the number of committed satellite cells, indicating that the exogenous S1P per se, without any stress-mediated signals, was unable to affect satellite cell functions (Figs 6 and 7) .
S1P affects extracellular matrix remodelling in EC-damaged muscle fibres
We finally evaluated the effects of S1P treatment on the remodelling of the extracellular matrix proteins. Staining of EDL muscle sections with Van Gieson, which stains collagen, revealed considerable reduced fibrosis in EC ϩ S1P compared with EC (Fig. 8A) . We also showed that the treatment with S1P up-regulated (approximately 2-fold) MMP-9 expression in EC-injured muscle (Fig. 8B) . Interestingly, EC treatment by itself increased MMP-9
Fig. 4 Effects of S1P on viability of satellite cell-enriched fractions from EC-injured EDL muscle. Cell viability was evaluated by MTS assay in satellite cell-enriched fractions 24 hrs after isolation from muscle in the indicated experimental conditions. Relative percentage to control set as 100 (mean Ϯ S.E.M.) is shown. Student's t-test, ***P Ͻ 0.01 versus control, n ϭ 4;
§ P Ͻ 0.01 versus EC, n ϭ 4. (Fig. 8C) , supporting the role of endogenous S1P and the activation of SphK1/S1P axis by EC in counteracting muscle tissue fibrosis.
Fig. 5 Effect of EC on
Discussion
S1P is a well-described bioactive lipid mediator which has been shown to mediate a wide variety of fundamental biological processes, including cell growth, survival, migration and differentiation. [44, 45] . Membrane-associated SphK1, the enzyme responsible for S1P production, can act as an exoenzyme, as shown in myogenic C2C12 cells [43] , and contribute to the autocrine/ paracrine action of the sphingoid molecule via the activation of specific S1P receptors [13, 14, 28] . Recent studies are beginning to highlight the importance of S1P in skeletal muscle homeostasis and disease, exerting a protective role against muscle atrophy and promoting myoblast differentiation and satellite cell activation [15, 16, [19] [20] [21] [22] [23] 46] . In [15] . The observed inability of S1P per se to affect satellite cells of uninjured tissue is in line with the recent findings showing that the specific S1P receptor isoform, S1P2, is rapidly up-regulated in skeletal muscle undergoing regeneration, but it is absent in quiescent cells [46] . [53] . Unfortunately, these events may be hindered in case of severe muscle wasting by the excessive deposition of collagen fibres in the form of a fibrotic scar which limits vascular perfusion of the injury site [54] 
It is generally accepted that dismantling the extracellular matrix is essential for myoblast migration, differentiation and fusion in vivo
